T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$1.68B |
| 2 |
Eli Lilly
LLY
|
+$1.43B |
| 3 |
Bank of America
BAC
|
+$1.17B |
| 4 |
Tesla
TSLA
|
+$1.13B |
| 5 |
Wells Fargo
WFC
|
+$734M |
Top Sells
| 1 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$20.6B |
| 2 |
Microsoft
MSFT
|
+$5.74B |
| 3 |
Amazon
AMZN
|
+$3.33B |
| 4 |
Yum! Brands
YUM
|
+$2.6B |
| 5 |
Salesforce
CRM
|
+$2.35B |
Sector Composition
| 1 | Technology | 26.11% |
| 2 | Healthcare | 18.73% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.33% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
851
Labcorp
LH
$23.2B
| $24.2M | ﹤0.01% |
137,340
-940,958
| -87% | -$166M |
|
852
Ingevity
NGVT
$2.14B
| $24M | ﹤0.01% |
396,073
-55,663
| -12% | -$3.38M |
|
|
ARCE
853
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
| $23.9M | ﹤0.01% |
2,219,409
-2,010
| -0.1% | -$21.7K |
|
854
Ventyx Biosciences
VTYX
$170M
| $23.9M | ﹤0.01% |
+685,342
| New | +$23.9M |
|
|
DRE
855
DELISTED
Duke Realty Corp.
DRE
| $23.8M | ﹤0.01% |
494,041
+1,748
| +0.4% | +$84.3K |
|
856
Sun Communities
SUI
$16.4B
| $23.8M | ﹤0.01% |
175,817
+3,509
| +2% | +$475K |
|
857
Flowserve
FLS
$7.41B
| $23.7M | ﹤0.01% |
975,700
-15,302
| -2% | -$372K |
|
858
Fortune Brands Innovations
FBIN
$7.29B
| $23.4M | ﹤0.01% |
510,877
-15,653
| -3% | -$718K |
|
859
Mid-America Apartment Communities
MAA
$16.9B
| $23.4M | ﹤0.01% |
150,691
-1,039
| -0.7% | -$161K |
|
860
TechTarget
TTGT
$429M
| $23.3M | ﹤0.01% |
394,395
-82,387
| -17% | -$4.88M |
|
861
Leidos
LDOS
$23.8B
| $23.2M | ﹤0.01% |
264,907
-2,211,485
| -89% | -$193M |
|
862
AXIS Capital
AXS
$7.76B
| $23M | ﹤0.01% |
468,188
-10,078,465
| -96% | -$495M |
|
863
Kellanova
K
$27.7B
| $23M | ﹤0.01% |
351,812
-11,794
| -3% | -$771K |
|
864
Five Below
FIVE
$8.04B
| $23M | ﹤0.01% |
166,734
-2,049,058
| -92% | -$282M |
|
865
Dorman Products
DORM
$5B
| $22.9M | ﹤0.01% |
278,760
-820,106
| -75% | -$67.4M |
|
866
Texas Pacific Land
TPL
$21.6B
| $22.7M | ﹤0.01% |
38,388
-89,415
| -70% | -$53M |
|
867
Amphastar Pharmaceuticals
AMPH
$1.33B
| $22.7M | ﹤0.01% |
808,731
+645,917
| +397% | +$18.2M |
|
|
XIFR
868
XPLR Infrastructure, LP
XIFR
$949M
| $22.6M | ﹤0.01% |
312,570
-1,875,722
| -86% | -$136M |
|
869
Kulicke & Soffa
KLIC
$2.03B
| $22.6M | ﹤0.01% |
585,679
+4,517
| +0.8% | +$174K |
|
870
Clorox
CLX
$15.2B
| $22.4M | ﹤0.01% |
174,069
-106,521
| -38% | -$13.7M |
|
871
Clearway Energy Class C
CWEN
$3.37B
| $22.3M | ﹤0.01% |
699,412
+55,459
| +9% | +$1.77M |
|
872
Tradeweb Markets
TW
$25.5B
| $22.1M | ﹤0.01% |
391,502
-9,402,657
| -96% | -$531M |
|
873
Principal Financial Group
PFG
$18.3B
| $21.9M | ﹤0.01% |
303,763
+8,378
| +3% | +$604K |
|
874
CONMED
CNMD
$1.67B
| $21.8M | ﹤0.01% |
272,463
+1,915
| +0.7% | +$154K |
|
875
Sana Biotechnology
SANA
$875M
| $21.8M | ﹤0.01% |
3,640,503
+748,922
| +26% | +$4.49M |
|